Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), bought 186,374 shares at $5.49 ($1.0M) on 2023-11-27, disclosed to the SEC on 2023-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.49 | 62,516 | $343K | 32.9% |
| 2 | $5.49 | 62,516 | $343K | 32.9% |
| 3 | $5.81 | 30,671 | $178K | 17.1% |
| 4 | $5.81 | 30,671 | $178K | 17.1% |
| Total | $5.60 avg | 186,374 | $1.0M | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |
| YMAB | SELL | 2021-06-11 | $812K | — | Filing → |